Imugene kicks off Australian trial for blood cancer treatment
Imugene Ltd (ASX:IMU) has opened the first Australian site for its clinical…
Change | ||
S&P/ASX Sm. Ords. | |||
All Ordinaries | |||
S&P/ASX 100 |
NVQ | NOVIQTECH LIMITED | 7.7¢ | 37.5% |
PLN | PIONEER LITHIUM LIMITED | 15.0¢ | 36.4% |
SNX | SIERRA NEVADA GOLD INC. | 5.3¢ | 29.3% |
BEL | BENTLEY CAPITAL LIMITED | 1.0¢ | 41.2% |
LAT | LATITUDE 66 LIMITED | 6.5¢ | 27.8% |
BGE | BRIDGE SAAS LIMITED | 2.1¢ | 27.6% |